ProMIS Neurosciences annual operating expenses
2021
2022
2023
2024
2025
ProMIS Neurosciences Operating Expenses Growth & History (PMN)
ProMIS Neurosciences's operating expenses was $40.2M for fiscal 2025.
View full ProMIS Neurosciences company overviewProMIS Neurosciences annual operating expenses history
| Fiscal year | Period ended | Operating expenses | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | $40.2M | $23.3M | +138.70% |
| 2024 | 2024-12-31 | $16.8M | $2.6M | +17.98% |
| 2023 | 2023-12-31 | $14.3M | −$9.1M | −39.00% |
| 2022 | 2022-12-31 | $23.4M | $15.1M | +181.99% |
| 2021 | 2021-12-31 | $8.3M | — | — |
ProMIS Neurosciences quarterly operating expenses
Q2.21
Q3.21
Q1.22
Q2.22
Q3.22
Q4.22
Q1.23
Q2.23
Q3.23
Q4.23
Q1.24
Q2.24
Q3.24
Q4.24
Q1.25
Q2.25
Q3.25
Q4.25
Q1.26
Q2.26
| Fiscal quarter | Period ended | Operating expenses | Change | YoY change |
|---|---|---|---|---|
| Q2 2026 | 2026-06-30 | $12.3M | $2.1M | +20.44% |
| Q1 2026 | 2026-03-31 | $8.6M | $1.2M | +15.88% |
| Q4 2025 | 2025-12-31 | $10.8M | $4.8M | +79.46% |
| Q3 2025 | 2025-09-30 | $11.8M | $7.3M | +164.97% |
| Q2 2025 | 2025-06-30 | $10.2M | $7.5M | +275.30% |
| Q1 2025 | 2025-03-31 | $7.5M | $3.8M | +102.90% |
| Q4 2024 | 2024-12-31 | $6.0M | $2.1M | +54.92% |
| Q3 2024 | 2024-09-30 | $4.4M | $1.9M | +76.15% |
| Q2 2024 | 2024-06-30 | $2.7M | −$186,178 | −6.42% |
| Q1 2024 | 2024-03-31 | $3.7M | −$1.3M | −26.03% |
| Q4 2023 | 2023-12-31 | $3.9M | −$4.6M | −54.54% |
| Q3 2023 | 2023-09-30 | $2.5M | −$3.5M | −58.42% |
| Q2 2023 | 2023-06-30 | $2.9M | −$2.0M | −40.39% |
| Q1 2023 | 2023-03-31 | $5.0M | $1.0M | +26.21% |
| Q4 2022 | 2022-12-31 | $8.5M | — | — |
| Q3 2022 | 2022-09-30 | $6.1M | $4.0M | +192.35% |
| Q2 2022 | 2022-06-30 | $4.9M | $3.8M | +340.07% |
| Q1 2022 | 2022-03-31 | $3.9M | — | — |
| Q3 2021 | 2021-09-30 | $2.1M | — | — |
| Q2 2021 | 2021-06-30 | $1.1M | — | — |
ProMIS Neurosciences operating expenses trends
Between the periods ended 2021-12-31 and 2025-12-31, ProMIS Neurosciences's operating expenses increased from $8.3M to $40.2M, a change of $31.9M. The latest reported quarter, Q2 2026, shows $12.3M.
About the metric
What operating expenses mean
Operating expenses are the recurring costs of running a company’s business beyond the direct costs used to calculate gross profit. They commonly include selling, general and administrative expenses, research and development, and other operating costs.
Calculation and source
SEC-reported and calculated operating expenses
TickerStat uses operating expenses reported in company SEC filings when available. When a separate total is unavailable, it calculates operating expenses as aligned gross profit minus operating income for the same fiscal period. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review ProMIS Neurosciences source filings ↗